However, pretreatment with Bati abrogated the Met@Man-MPs-induced tumor accumulation of anti-PD-1 antibody, suggesting that the collagen degradation capability of Met@Man-MPs is responsible for the enhanced tumor accumulation of anti-PD-1 antibody. The gene discussed is PDCD1; the disease is neoplasm.